Holen Sie sich die Stockscreener-App
338.67
0.25%
0.9185
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt WST?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$337.75
Offen:
$337.63
24-Stunden-Volumen:
98,799
Relative Volume:
0.15
Marktkapitalisierung:
$23.83B
Einnahmen:
$3.22B
Nettoeinkommen (Verlust:
$542.70M
KGV:
45.27
EPS:
7.4805
Netto-Cashflow:
$458.00M
1W Leistung:
-1.17%
1M Leistung:
-4.37%
6M Leistung:
+36.50%
1J Leistung:
+34.35%
1-Tages-Spanne:
$336.10
$340.48
1-Wochen-Bereich:
$334.04
$345.50
52-Wochen-Spanne:
$223.83
$386.00
West Pharmaceutical Services Inc Stock (WST) Company Profile
Firmenname
West Pharmaceutical Services Inc
Sektor
Telefon
(610) 594-2900
Adresse
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
338.66 | 23.77B | 3.22B | 542.70M | 458.00M | 7.4805 |
ISRG
Intuitive Surgical Inc
|
351.58 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.32 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.05 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.75 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.38 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2025-09-15 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-06-24 | Eingeleitet | Barclays | Equal Weight |
| 2025-03-18 | Eingeleitet | Evercore ISI | Outperform |
| 2025-02-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-01-08 | Eingeleitet | Citigroup | Buy |
| 2024-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-12-12 | Hochstufung | UBS | Neutral → Buy |
| 2024-02-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-06-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-04-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-11-30 | Eingeleitet | UBS | Neutral |
| 2022-10-28 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Eingeleitet | Stephens | Equal-Weight |
| 2020-07-21 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-04-24 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | Herabstufung | Jefferies | Buy → Hold |
| 2019-04-23 | Eingeleitet | William Blair | Outperform |
| 2018-04-25 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2017-10-17 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | Eingeleitet | Stephens | Equal-Weight |
| 2017-09-15 | Hochstufung | Jefferies | Hold → Buy |
| 2016-10-28 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | Eingeleitet | Wells Fargo | Outperform |
| 2010-05-14 | Bestätigt | UBS | Neutral |
| 2010-02-23 | Eingeleitet | Jefferies & Co | Buy |
| 2008-12-19 | Eingeleitet | UBS | Neutral |
Alle ansehen
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store? - Zacks Investment Research
West Pharmaceutical stock heads before the bell after a 0.8 percent drop - AD HOC NEWS
West Pharmaceutical (NYSE:WST): Has the Growth Story Been Priced In? - Kalkine Media
West Pharmaceutical stock gains after strong Q2 figures - AD HOC NEWS
Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? - Yahoo Finance
West Pharmaceutical Services (WST) Stock Analysis: Unveiling a Potential 19% Upside in the Healthcare Sector - DirectorsTalk Interviews
Rubber Gaskets Pharmaceutical Containers Market Outlook to 2035 - IndexBox
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap - Yahoo Finance
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
West Pharmaceutical Services stock holds steady as investors eye recent rating and earnings momentum - AD HOC NEWS
West Pharma Sets September Investor Conference Appearances - MyChesCo
West Pharmaceutical (NYSE:WST) Draws Attention As Fair Value Rises - Kalkine Media
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical stock gains on strong Q2 2026 earnings and guidance - AD HOC NEWS
West Pharmaceutical stock holds above $340 as analysts target higher gains - AD HOC NEWS
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical stock holds steady as analysts maintain a moderate buy view - AD HOC NEWS
West Pharmaceutical Services (WST): Investor Outlook with a Promising 19.93% Upside Potential - DirectorsTalk Interviews
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? - webull.com
West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors - MarketWatch
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
16,794 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Cibc World Market Inc. - MarketBeat
West to Participate in Upcoming Investor Conferences - PR Newswire
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
West Pharmaceutical Services (WST) Stock Analysis: Riding a 14.63% Potential Upside with Strong Analyst Confidence - DirectorsTalk Interviews
West Pharmaceutical Services, Inc. (WPS) Q2 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical Services, Inc. (WPS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
West Pharmaceutical stock holds firm after Q2 beat - Ad-hoc-news.de
NFJ Investment Group LLC Invests $7.76 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Wealthfront Advisers LLC Acquires Shares of 6,440 West Pharmaceutical Services, Inc. $WST - MarketBeat
2,043,823 Shares in West Pharmaceutical Services, Inc. $WST Bought by Bank of New York Mellon Corp - MarketBeat
West Pharmaceutical Services (WST) Gains Momentum On An Undervalued Narrative - Yahoo Finance
West Pharmaceutical stock holds firm as analysts lift targets - Ad-hoc-news.de
Madison Asset Management LLC Invests $9.90 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $67.58 Million Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Generation Investment Management LLP Invests $728.17 Million in West Pharmaceutical Services, Inc. $WST - MarketBeat
410,699 Shares in West Pharmaceutical Services, Inc. $WST Acquired by Deutsche Bank AG - MarketBeat
BlackRock Inc. Buys Shares of 6,651,784 West Pharmaceutical Services, Inc. $WST - MarketBeat
Join Class Action to Recover Losses from West Pharmaceutical Serv - The National Law Review
West Pharmaceutical stock steadies after institutional buying as shares trade near 52-week highs - Ad-hoc-news.de
Meeder Asset Management Inc. Makes New Investment in West Pharmaceutical Services, Inc. $WST - MarketBeat
Pallas Capital Advisors LLC Acquires New Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical's Long-Term Growth Intact - Morningstar
West Pharmaceutical Services (WST): Analyst Consensus And 15.83% Potential Upside - DirectorsTalk Interviews
Is West Pharmaceutical Services (WST) Undervalued After Its Run to $349.42? - Sahm
West Pharmaceutical Services (WST) Holds Above $349 as Shares Edge Higher — Key Levels in FocusMcClellan Summation - vinanet.vn
WST Stock Surges 38.1% Since March-End: What's Fueling the Rally? - Yahoo Finance
Finanzdaten der West Pharmaceutical Services Inc-Aktie (WST)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):